Myelin Integrity Clinical Trial
Official title:
Scan-rescan Reproducibility of Myelin Sensitive MRI Techniques
Verified date | December 2021 |
Source | University Hospital, Basel, Switzerland |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study is to assess the variation in the measurements of myelin sensitive MRI techniques in both white and grey matter in the brain.
Status | Completed |
Enrollment | 13 |
Est. completion date | September 30, 2021 |
Est. primary completion date | September 30, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - No neurological or psychiatric disorder Exclusion Criteria: - Pregnancy - Contraindication to MRI (eg, claustrophobia, metallic implants, pacemaker etc). - Inability to give consent. |
Country | Name | City | State |
---|---|---|---|
Switzerland | Neurologische Klinik und Poliklinik, University Hospital Basel | Basel |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Basel, Switzerland | Hoffmann-La Roche |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | analysis of variance between MTI, SBI, MWI, T1 relaxometry and multi-shell diffusion obtained in each subject in each of the 3 scan sessions | statistical analysis of variance between MTI, SBI, MWI, T1 relaxometry and multi-shell diffusion obtained in each subject in each of the 3 scan sessions | 1 hour total scan time (during a time period of max. 1 week) |